Madrigal Pharmaceuticals Secures Key Patent for Rezdiffra, Extending Market Protection to 2044
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced this week that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new patent …
Madrigal Pharmaceuticals Secures Key Patent for Rezdiffra, Extending Market Protection to 2044 Read More